Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Cancer
; 129(1): 71-81, 2023 01 01.
Article
in En
| MEDLINE
| ID: mdl-36309837
Full text:
1
Collection:
01-internacional
Health context:
3_ND
Database:
MEDLINE
Main subject:
Neoplasms, Second Primary
/
Neoplasms
Limits:
Adult
/
Humans
Language:
En
Journal:
Cancer
Year:
2023
Document type:
Article